0,861  0,003  Sensitization
0,856  0,009  Antiinflammatory
0,824  0,004  Bone diseases treatment
0,801  0,004  Antipsoriatic
0,790  0,005  Antiosteoporotic
0,772  0,020  Apoptosis agonist
0,746  0,014  CYP3A4 substrate
0,725  0,011  Antileukemic
0,729  0,020  Caspase 9 stimulant
0,703  0,010  Respiratory analeptic
0,696  0,004  UGT1A4 substrate
0,674  0,014  CYP2C9 substrate
0,661  0,005  Antipruritic, allergic
0,661  0,026  Antineoplastic (breast cancer)
0,640  0,008  Antineoplastic (pancreatic cancer)
0,614  0,005  Antineoplastic enhancer
0,619  0,013  CYP2C19 substrate
0,630  0,026  Antineoplastic (lung cancer)
0,618  0,029  Transcription factor NF kappa B inhibitor
0,602  0,025  TNF expression inhibitor
0,600  0,024  Teratogen
0,583  0,015  Analeptic
0,578  0,011  Nitric oxide antagonist
0,568  0,003  Aromatase inhibitor
0,564  0,005  Prostatic (benign) hyperplasia treatment
0,567  0,018  Immunosuppressant
0,569  0,021  Prostate cancer treatment
0,570  0,025  Embryotoxic
0,547  0,004  Contraceptive
0,550  0,017  Immunomodulator
0,536  0,004  Antiacne
0,528  0,005  Non-steroidal antiinflammatory agent
0,529  0,007  Antineoplastic (liver cancer)
0,534  0,012  Antipyretic
0,540  0,022  Antineoplastic (ovarian cancer)
0,525  0,008  UGT2B4 substrate
0,534  0,017  Hepatic disorders treatment
0,514  0,004  Prostate disorders treatment
0,525  0,021  Antineoplastic (melanoma)
0,508  0,004  UGT2B7 substrate
0,493  0,004  Antifungal enhancer
0,489  0,003  Antipruritic, non-allergic
0,476  0,005  Antidiabetic (type 1)
0,477  0,008  Hair growth stimulant
0,483  0,025  Carcinogenic
0,460  0,014  UDP-glucuronosyltransferase substrate
0,459  0,014  Sigma receptor agonist
0,463  0,025  NOS3 expression inhibitor
0,457  0,023  Antineoplastic (multiple myeloma)
0,446  0,012  Calcium channel activator
0,459  0,026  Apoptosis antagonist
0,458  0,026  Antineoplastic (glioma)
0,440  0,009  Antiparkinsonian, rigidity relieving
0,456  0,027  Chemoprotective
0,434  0,009  Interferon gamma antagonist
0,448  0,024  Chemopreventive
0,431  0,011  Abortion inducer
0,449  0,034  Antihypercholesterolemic
0,435  0,024  Proliferative diseases treatment
0,414  0,004  Contraceptive female
0,428  0,018  Antihypoxic
0,421  0,015  UGT1A1 substrate
0,420  0,014  Anesthetic general
0,436  0,031  Lipoprotein disorders treatment
0,440  0,042  Cholesterol antagonist
0,395  0,005  Antiinfertility, female
0,399  0,009  Antialcoholic
0,412  0,023  UGT1A6 substrate
0,422  0,033  Cytotoxic
0,417  0,029  NOS2 expression inhibitor
0,401  0,017  Sodium/bile acid cotransporter inhibitor
0,424  0,048  Antineoplastic (colorectal cancer)
0,380  0,005  UGT2B9 substrate
0,421  0,052  CYP2C19 inhibitor
0,405  0,038  Radioprotector
0,391  0,027  Hypolipemic
0,386  0,022  Antiulcerative
0,398  0,035  UGT1A9 substrate
0,364  0,008  Sulfotransferase substrate
0,385  0,029  Tumour necrosis factor alpha release inhibitor
0,403  0,049  Antineoplastic (colon cancer)
0,361  0,011  UGT2B15 substrate
0,392  0,042  AR expression inhibitor
0,346  0,003  5-Alpha-reductase inhibitor
0,363  0,020  Muscle relaxant
0,355  0,013  Lipocortins synthesis antagonist
0,339  0,004  Farnesoid X receptor antagonist
0,362  0,028  Antineoplastic (endocrine cancer)
0,360  0,026  Interleukin agonist
0,347  0,015  Anesthetic
0,341  0,012  Sepsis treatment
0,334  0,005  LDLR expression enhancer
0,362  0,034  Antineoplastic (lymphoma)
0,322  0,003  Hypercalcemia treatment
0,335  0,021  Hepatoprotectant
0,313  0,003  Progesterone antagonist
0,306  0,004  Pregnane X receptor agonist
0,324  0,027  Platelet adhesion inhibitor
0,340  0,048  Antineoplastic (cervical cancer)
0,304  0,014  Interleukin 6 antagonist
0,306  0,020  UGT1A3 substrate
0,325  0,040  Antineoplastic (glioblastoma multiforme)
0,277  0,003  Hyperparathyroidism treatment
0,295  0,023  Diuretic
0,279  0,008  Androgen antagonist
0,374  0,106  Antidiabetic
0,374  0,106  Cyclophilin D inhibitor
0,267  0,005  ABCA1 expression enhancer
0,269  0,009  UGT2B10 substrate
0,330  0,072  ICAM1 expression inhibitor
0,261  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,294  0,037  Gastrin inhibitor
0,267  0,021  Antiviral (Influenza A)
0,248  0,005  Actinic keratosis treatment
0,245  0,005  Keratolytic
0,249  0,010  SULT1A1 substrate
0,312  0,075  Antifungal
0,274  0,040  Sedative
0,243  0,014  Endometrios treatment
0,252  0,029  Skeletal muscle relaxant
0,259  0,036  Pneumotoxic
0,224  0,002  Vitamin D receptor antagonist
0,255  0,035  Neurotrophic factor enhancer
0,293  0,074  Cardioprotectant
0,220  0,004  Paget's disease treatment
0,277  0,063  Antineoplastic (renal cancer)
0,318  0,105  Antiobesity
0,220  0,008  TRPA1 agonist
0,225  0,014  Arachidonic acid antagonist
0,238  0,028  CNS active muscle relaxant
0,279  0,070  Antioxidant
0,221  0,012  Menstruation disorders treatment
0,221  0,013  UGT2B1 substrate
0,251  0,044  Antihelmintic
0,264  0,058  Antineoplastic (sarcoma)
0,214  0,010  Contraceptive male
0,216  0,017  Antieczematic
0,312  0,116  Antiprotozoal
0,198  0,004  Anabolic
0,252  0,060  Antiparasitic
0,240  0,050  Antiviral (Influenza)
0,292  0,104  Antiprotozoal (Plasmodium)
0,260  0,072  5 Hydroxytryptamine uptake stimulant
0,219  0,031  Bone formation stimulant
0,254  0,070  Cardiovascular analeptic
0,230  0,048  CYP2B6 inhibitor
0,215  0,037  Protein kinase stimulant
0,181  0,004  Liver X receptor alpha agonist
0,185  0,010  Inducible nitric-oxide synthase inhibitor
0,243  0,070  Cytostatic
0,174  0,003  5-Alpha-reductase 2 inhibitor
0,229  0,059  Mutagenic
0,197  0,028  Antihyperlipoproteinemic
0,178  0,009  Estrogen agonist
0,265  0,098  CYP2D6 substrate
0,209  0,043  Antipruritic
0,253  0,090  Spasmolytic
0,165  0,003  Retinoid X alpha receptor agonist
0,202  0,041  Toxic, respiratory center
0,163  0,003  5-Alpha-reductase 1 inhibitor
0,199  0,041  Melanin inhibitor
0,187  0,030  Cholesterol synthesis inhibitor
0,296  0,139  Antibacterial
0,165  0,010  UGT2B11 substrate
0,223  0,071  RNA-directed DNA polymerase inhibitor
0,233  0,082  Antiprotozoal (Leishmania)
0,229  0,080  Angiogenesis stimulant
0,152  0,008  Cannabinoid CB2 receptor antagonist
0,252  0,107  CTGF expression inhibitor
0,191  0,046  Antiparkinsonian, tremor relieving
0,256  0,113  Interleukin 2 agonist
0,181  0,040  SULT1A3 substrate
0,167  0,027  Nav1.1 sodium channel blocker
0,142  0,002  CYP24 inhibitor
0,141  0,002  Parathyroid hormone antagonist
0,288  0,150  Analgesic
0,144  0,009  Bile acid receptor antagonist
0,159  0,025  HDL-cholesterol increasing
0,135  0,003  Retinoid X receptor agonist
0,209  0,079  VCAM1 expression inhibitor
0,160  0,030  Vanilloid 1 agonist
0,138  0,008  Androgen agonist
0,137  0,008  SULT1A2 substrate
0,166  0,038  Retinoprotector
0,145  0,018  Antiviral (SARS coronavirus)
0,145  0,018  Antiviral (Coronavirus)
0,139  0,013  Postmenopausal disorders treatment
0,227  0,101  Antineoplastic (bladder cancer)
0,148  0,023  Nitric-oxide synthase inhibitor
0,134  0,010  Na+ K+ transporting ATPase inhibitor
0,181  0,058  Phobic disorders treatment
0,137  0,015  CDC25A inhibitor
0,146  0,025  Estrogen antagonist
0,173  0,052  Antineoplastic (squamous cell carcinoma)
0,136  0,017  Tocolytic
0,129  0,010  Glycine receptor agonist
0,230  0,111  Antiepileptic
0,154  0,035  Microtubule formation inhibitor
0,161  0,043  Skin irritative effect
0,131  0,015  Estrogen receptor alpha antagonist
0,171  0,056  NOS3 expression enhancer
0,125  0,011  Narcotic antagonist
0,119  0,005  Potassium channel Kv1.3 blocker
0,148  0,035  Alcohol dehydrogenase substrate
0,131  0,019  Ornithine decarboxylase inhibitor
0,186  0,074  P-glycoprotein inhibitor
0,168  0,059  Antineoplastic (carcinoma)
0,228  0,119  CYP1A2 substrate
0,117  0,009  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,128  0,021  Opioid kappa receptor antagonist
0,149  0,042  Growth stimulant
0,249  0,143  Stroke treatment
0,212  0,106  DNA damaging
0,155  0,050  Cocaine dependence treatment
0,135  0,029  Prolactin inhibitor
0,109  0,005  Liver X receptor antagonist
0,108  0,004  Liver X receptor alpha antagonist
0,185  0,081  VEGF expression inhibitor
0,149  0,046  Protein-tyrosine phosphatase 1B inhibitor
0,104  0,005  Postcoital contraceptive
0,114  0,016  Cushing's syndrome treatment
0,100  0,005  Glucocorticoid antagonist
0,153  0,058  Adenylate cyclase stimulant
0,123  0,029  Estrogen receptor beta antagonist
0,097  0,008  Liver X receptor agonist
0,104  0,016  Anticholelithogenic
0,091  0,004  Liver X receptor beta antagonist
0,121  0,039  Hedgehog signaling inhibitor
0,096  0,014  Acetyl-CoA transferase inhibitor
0,128  0,047  Choleretic
0,142  0,062  Nav1.2 sodium channel blocker
0,102  0,022  Estrogen-related receptor beta agonist
0,235  0,157  Ulceration
0,088  0,011  Heme oxygenase stimulant
0,138  0,061  Carcinogenic, group 3
0,220  0,144  Antineoplastic (brain cancer)
0,090  0,013  Estrogen receptor beta agonist
0,077  0,002  Retinoid X beta receptor antagonist
0,191  0,117  Vascular (periferal) disease treatment
0,151  0,078  Protein-tyrosine phosphatase inhibitor
0,076  0,003  Retinoid X receptor antagonist
0,159  0,090  Tumour necrosis factor antagonist
0,077  0,008  RNA-directed RNA polymerase stimulant
0,073  0,005  Alpha 1L adrenoreceptor agonist
0,137  0,070  Psychosexual dysfunction treatment
0,215  0,148  Caspase 3 stimulant
0,079  0,012  Estrogen receptor alpha agonist
0,072  0,006  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,092  0,027  Potassium channel large-conductance Ca-activated activator
0,081  0,016  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,136  0,071  Amylase inhibitor
0,067  0,003  Retinoid X alpha receptor antagonist
0,173  0,110  Histone acetyltransferase inhibitor
0,097  0,036  Vanilloid agonist
0,076  0,016  Lipocortins synthesis agonist
0,124  0,064  Anesthetic local
0,123  0,063  Autism spectrum disorders treatment
0,127  0,068  Antiseptic
0,128  0,071  Acetylcholinesterase inhibitor
0,076  0,019  Calcium channel P-type blocker
0,095  0,038  Glycine receptor antagonist
0,071  0,014  Mineralocorticoid receptor antagonist
0,142  0,085  Raynaud's phenomenon treatment
0,102  0,046  Opioid antagonist
0,140  0,085  Insulin secretagoues
0,095  0,039  3C-Like protease (SARS coronavirus) inhibitor
0,080  0,025  SULT2A1 substrate
0,141  0,087  Eye irritation, high
0,090  0,037  T cell inhibitor
0,139  0,088  Antiviral (Herpes)
0,079  0,029  CDC25B inhibitor
0,078  0,028  Uterine relaxant
0,055  0,004  Progesterone agonist
0,058  0,009  Liver X receptor beta agonist
0,074  0,026  Transcription factor AP-1 inhibitor
0,053  0,006  Cholesterol ester transfer protein antagonist
0,063  0,017  Opioid kappa receptor agonist
0,118  0,073  Antiprotozoal (Amoeba)
0,155  0,111  Psychostimulant
0,139  0,097  Movement disorders treatment
0,206  0,164  CYP3A4 inhibitor
0,054  0,013  Acetyl-CoA transferase 1 inhibitor
0,179  0,139  Antihypotensive
0,050  0,011  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,043  0,004  Progesterone receptor B antagonist
0,130  0,093  Genotoxic
0,094  0,057  SULT1E1 substrate
0,041  0,004  Retinoid X gamma receptor antagonist
0,057  0,022  Aldosterone antagonist
0,164  0,130  Antineoplastic (lymphocytic leukemia)
0,061  0,027  Lysine-specific demethylase 1A inhibitor
0,071  0,038  Glutamate (mGluR6) antagonist
0,075  0,043  Opioid mu receptor antagonist
0,057  0,026  Anesthetic inhalation
0,137  0,106  Liver fibrosis treatment
0,091  0,060  Glutamate release inhibitor
0,037  0,008  Retinoid X gamma receptor agonist
0,041  0,012  ATP citrate lysase inhibitor
0,033  0,004  NMDA receptor phencyclidine site antagonist
0,042  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,082  0,056  Antineoplastic antibiotic
0,085  0,060  Transcription factor NF kappa B stimulant
0,048  0,023  Glutamate (mGluR group III) antagonist
0,201  0,176  Antithrombotic
0,165  0,141  Acute neurologic disorders treatment
0,070  0,046  Premenstrual syndrome treatment
0,050  0,027  Adenylate cyclase 1 inhibitor
0,107  0,085  Shock treatment
0,026  0,004  Vitamin D receptor agonist
0,048  0,026  Estradiol 17 beta-dehydrogenase inhibitor
0,038  0,017  HMG CoA reductase inhibitor
0,091  0,071  Anticataract
0,040  0,021  Glucose-6-phosphate dehydrogenase inhibitor
0,031  0,012  Hedgehog signaling activator
0,131  0,114  Uterine stimulant
0,168  0,153  Antiprotozoal (Trypanosoma)
0,027  0,012  Estrone sulfatase inhibitor
0,025  0,011  Retinoic acid gamma receptor agonist
0,014  0,001  Vitamin D-like
0,024  0,011  Retinoid X beta receptor agonist
0,176  0,163  Antidiabetic (type 2)
0,023  0,011  Retinoic acid alpha receptor antagonist
0,047  0,036  Sigma receptor antagonist
0,156  0,146  Antineoplastic (non-small cell lung cancer)
0,060  0,050  Antiemphysemic
0,023  0,013  Corticosteroid-like
0,014  0,004  Progesterone receptor A antagonist
0,020  0,011  Retinoic acid receptor antagonist
0,166  0,158  5 Hydroxytryptamine release stimulant
0,081  0,073  Antineoplastic, alkylator
0,022  0,016  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,084  0,077  Butyrylcholinesterase inhibitor
0,013  0,007  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,045  0,039  Cholesterol esterase inhibitor
0,117  0,112  Cholinergic
0,054  0,049  Bombesin 1 receptor agonist
0,085  0,081  Lanosterol 14 alpha demethylase inhibitor
0,035  0,030  Farnesoid X receptor agonist
0,094  0,092  DNA polymerase I inhibitor
0,038  0,036  Hypogonadism treatment
0,109  0,107  Interleukin 1 antagonist
0,153  0,152  Immunostimulant
0,069  0,069  Acetylcholine nicotinic antagonist

